• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Actelion - Articles and news items

FDA approves Uptravi for pulmonary arterial hypertension

Industry news / 23 December 2015 / Victoria White

Uptravi (selexipag) acts by relaxing muscles in the walls of blood vessels to dilate (open) blood vessels and decrease the elevated pressure in the vessels supplying blood to the lungs…

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +